|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City | 330 N. Wabash Avenue, Chicago |
State | IL |
Zip Code | 60611 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2014 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III |
Date | 10/17/2014 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 1180, Resident Physician Shortage Reduction Act of 2013, all provisions
S. 577, Resident Physician Shortage Reduction Act of 2013, all provisions
H.R. 4282, Creating Access to Residency Education Act of 2014, all provisions
Graduate Medical Education
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Kristen |
O'Brien |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 2529, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2014, all provisions
S. 2645, Recovery Enhancement for Addiction Treatment (TREAT) Act, all provisions
H.R. 3229, Indian Health Service Advance Appropriations Act of 2013, all provisions
S. 1570, Indian Health Service Advance Appropriations Act of 2013, all provisions
H.R. 4843, Native Contract and Rate Expenditure Act of 2014, all provisions
H.R. 1701, Cutting Costly Codes Act of 2013, all provisions
S. 972, Cutting Costly Codes Act of 2013, all provisions
H.R. 3742, Antibiotic Development to Advance Patient Treatment (ADAPT) Act of 2013, all provisions
ACA Implementation
Prescription requirements for OTC medications
Electronic Health Records Meaningful Use Regulations
Opioid abuse, diversion control and treatment
Prescription drug abuse/pain management/prescriber education
Telemedicine
ICD-10 Repeal
CPT
HIPAA
Health Care Data
Open Payments Regulations (Sunshine Act)
Laboratory Developed Tests
Personalized Medicine
21st Century Cures Initiative
Mental Health
Diabetes
Nutrition Labeling
Drug Compounding
Biosimilars
Clinical Data Registries
Exchanges
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), White House Office, Office of Natl Drug Control Policy (NDCP), Drug Enforcement Administration (DEA), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matt |
Reid |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
Koryn |
Rubin |
|
|
|
Mari |
Savickis |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
|
Debra |
Cohn |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
H.R. 1180, Resident Physician Shortage Reduction Act of 2013, all provisions
S. 577, Resident Physician Shortage Reduction Act of 2013, all provisions
H.R. 4282, Creating Access to Residency Education Act of 2014, all provisions
Medical Licensure - Assistant physician designation
Interstate Medical Licensure Compact
Biosimilars
Meaningful Use Data Lock-in
Antitrust
17. House(s) of Congress and Federal agencies Check if None
Federal Trade Commission (FTC), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Margaret |
Garikes |
|
|
|
Matt |
Reid |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
George |
Cox |
III |
|
|
Kristen |
O'Brien |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1179, Improving Access to Medicare Coverage Act of 2013, all provisions
S. 569, Improving Access to Medicare Coverage Act of 2013, all provisions
H.R. 4015, SGR Repeal and Medicare Provider Payment Modernization Act of 2014, all provisions
S. 2000, SGR Repeal and Medicare Provider Payment Modernization Act of 2014, all provisions
H.R. 1180, Resident Physician Shortage Reduction Act of 2013, all provisions
S. 577, Resident Physician Shortage Reduction Act of 2013, all provisions
H.R. 962, Medicare Diabetes Prevention Act of 2013, all provisions
S. 452, Medicare Diabetes Prevention Act of 2013, all provisions
H.R. 4302, Protecting Access to Medicare Act of 2014, provisions relating to Physician Payment Reform/SGR Repeal
S. 2501, Hospital Readmissions Program Accuracy and Accountability Act of 2014, all provisions
S. 2694, Ensuring Access to Primary Care for Women & Children Act, all provisions
S. 2552, Medicare Advantage Participant Bill of Rights Act of 2014, all provisions
S. 1180, Medicare Data Access for Transparency and Accountability Act, all provisions
H.R. 3698, Two-Midnight Rule Delay Act of 2013, all provisions
H.R. 4282, Creating Access to Residency Education Act of 2014, all provisions
H.R. 5481, To continue the use of a 3-month quarter EHR reporting period for health care providers to demonstrate meaningful use for 2015 under the Medicare and Medicaid EHR incentive payment programs, and for other purposes, all provisions
Medicare program: Protecting Integrity in Medicare Act (PIMA) of 2014
Medicare program: Stop Scams Act
Medicare program: Medicare Advantage
Medicare program: Medicare Part D
Medicare program: Medicare claims data release
Medicare program: SGR Repeal
Medicare program: Graduate Medical Education
Medicare program: Sunshine Act (Open Payments Program) Notice of a New System of Records
Medicare program: Electronic Health Records Meaningful Use Regulations/program flexibility
Medicare program: ICD-10 Repeal
Medicare program: CPT
Medicare program: HIPAA
Medicare program: RUC - Misvalued and Care Coordination Codes
Medicare program: Local Coverage Determinations
Medicare program: Physician payment and delivery reform
Medicare program: Physician Compare
Medicare program: Telemedicine and Medicare payment policy
Medicare program: Practice Transformation
Medicare program: In-Office Ancillary Services Exception
Medicare program: Independent Payment Advisory Board (IPAB) Repeal
Medicare program: Private Contracting
Medicare program: New payment models/measuring quality performance
Medicare program: Hospital short-stay issue
Medicare program: Physician Consortium for Performance Improvement (PCPI)
Medicare program: Recovery Audit Contractors
Medicare program: Program Integrity
Medicare program: Home health
Medicare program: Funding for quality measure development
Medicare program: Payment neutrality/hospital inpatient and outpatient sites
Medicare program: Value-Based Modifier and Quality Resource Use Reports
Medicare program: Laboratory Developed Tests - coding, coverage and payment
Medicaid program: Medicaid expansion
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Government Accountability Office (GAO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matt |
Reid |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
Koryn |
Rubin |
|
|
|
Mari |
Savickis |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
|
Debra |
Cohn |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Durbin Amendment: Prohibiting sale of tobacco products in military resale outlets at discount prices
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 1733, Good Samaritan Health Professionals Act of 2013, all provisions
S. 2196, Good Samaritan Health Professionals Act of 2013, all provisions
H.R. 1473, Standard of Care Protection Act of 2013, all provisions
S. 1769, Standard of Care Protection Act of 20113, all provisions
Medical Liability Reform
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Andrew |
Wankum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
H.R. 4810, Veteran Access to Care Act of 2014, all provisions
S. 2450, Veterans' Access to Care through Choice, Accountability, and Transparency Act of 2014 (passed Senate as H.R. 3230)
House Committee on Appropriations Report 113-416 accompanying H.R. 4486, the Military Construction and Veterans Affairs Related Agencies Appropriations Act, 2015, provisions relating to draft Veterans Health Administration Nursing Handbook
Veterans Affairs Reform
Private practice physician
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
House Committee on Appropriations Report 113-416 accompanying H.R. 4486, the Military Construction and Veterans Affairs Related Agencies Appropriations Act, 2015, provisions relating to draft Veterans Health Administration Nursing Handbook
H.R. 3229, Indian Health Service Advance Appropriations Act of 2013, all provisions
S. 1570, Indian Health Service Advance Appropriations Act of 2013, all provisions
H.R. 4843, Native Contract and Rate Expenditure Act of 2014, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |